Strive, Inc. (ASST) has moved within a fairly tight band over the past month. Shares slipped from roughly $29.94 in late September to around $28.97 by the close on October 23, 2026, for a decline of about 3%. Intraday swings have been noticeable, which aligns with the stock’s role as a Bitcoin-linked treasury name that reacts to both crypto prices and its own financing moves. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sentiment stays closely linked to the broader digital-asset market and to the company’s continued accumulation approach. Even as Bitcoin holdings have expanded, shareholders have felt the impact of dilution from warrant exercises and preferred-stock issuance, keeping the price largely range-bound despite a positive analyst note.
Strive, Inc. positions itself as the first publicly traded asset-management Bitcoin treasury company, with a focus on growing Bitcoin holdings per share to potentially outperform the cryptocurrency over time. The firm resulted from Asset Entities Inc. merging with Strive Enterprises, Inc. in September 2025 and later combining with Semler Scientific in January 2026.
Its subsidiary, Strive Asset Management, LLC, is an SEC-registered adviser that oversees several billion dollars and provides sub-advisory services for the Strive ETF family. This combination of an asset-management business with a Bitcoin treasury sets it apart from pure-play holders and draws interest from investors seeking leveraged exposure to digital assets alongside an operating franchise.
Strive disclosed buying 4,045 Bitcoin between October 12 and 16 at an average price near $82,803, bringing total holdings to 36,818 BTC valued at roughly $3 billion at the time. Part of the funding came from warrant exercises that raised about $369 million, though common shares outstanding increased from roughly 110.4 million to 124.1 million, which offset some of the per-share gain in the treasury.
Separately, the company priced seven million shares of 15% Series A Perpetual Preferred Stock (SATS) at $90 each, raising approximately $630 million, with trading on Nasdaq beginning around October 20, 2026. On the research side, TD Cowen lifted its price target from $44 to $56 on October 16, pointing to faster-than-expected Bitcoin purchases even as the share price lagged the new target.
Several elements will likely shape the outlook for ASST. The pace of Bitcoin accumulation and the cost of capital will stay central, especially with preferred-stock dividends building over time. Investors will track the balance between share count and Bitcoin holdings, since further issuance can dilute per-share exposure even as the treasury expands.
Broader influences include Bitcoin’s price path, institutional adoption of digital-asset products, and results from the asset-management side. Regulatory shifts and any further analyst updates could also affect sentiment. These points offer a factual basis for review rather than a forecast of returns.
In my own process, I frequently review Tickeron’s Trending AI Robots to observe how automated strategies are responding to volatile names like this one. The page highlights top-performing bots across strategies and timeframes, letting users compare signals without relying on any single approach. It provides a practical way to track how systematic trading reacts to news and price swings in the current environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for ASST turned negative on September 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In 24 of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASST's RSI Oscillator exited the oversold zone, 22 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ASST as a result. In 57 of 63 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.
Following a +20.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 140 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 61 of 78 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.378) is normal, around the industry mean (2.409). P/E Ratio (-39.088) is within average values for comparable stocks, (-3.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.271) among similar stocks. ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.798).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers